Anti-MAP2 antibody - Neuronal Marker and 6 more items

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, awarded a purchase order contract to ABCAM INC on February 4, 2026, for a total contract value of $3,410.00. The contract is scheduled for completion on February 11, 2026, with delivery to the UNMC Pharmacology & Experimental Neuroscience department located at 601 Saddle Creek Road in Omaha, Nebraska. The contract was awarded under standard purchase order terms with Net 30 payment conditions and F.O.B. destination freight prepaid.

The contract encompasses seven research-grade antibody products, each ordered in single-unit quantities for neurobiological research applications. The line items include Anti-MAP2 antibody (neuronal marker, $410.00), Anti-CD68 antibody [KP1] ($405.00), Anti-TMEM119 antibody [28-3] (microglia marker, $405.00), Anti-P2Y12 antibody [EPR23511-72] ($615.00), Anti-PSD95 antibody [6G6-1C9] (synaptic marker, $405.00), Anti-Gephyrin antibody [EPR12650] ($530.00), and Anti-GAD65 antibody [EPR22952-70] ($640.00). Payment will be made through Nebraska State Treasury warrants under UNMC's tax-exempt status.